{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:24:38Z","timestamp":1790825078908,"version":"4.1.0"},"reference-count":46,"publisher":"The Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7,1]]},"abstract":"<jats:p>Estrogens have been shown to have protective effects on a wide range of cell types and animal models for many neurodegenerative diseases. The present study demonstrates the cytoprotective effects of 17\u03b2-estradiol (E2) and estrogen-like compounds in an in vitro model of Friedreich's ataxia (FRDA) using human donor FRDA skin fibroblasts. FRDA fibroblasts are extremely sensitive to free radical damage and oxidative stress, produced here using l-buthionine (S,R)-sulfoximine to inhibit de novo glutathione synthesis. We have shown that the protective effect of E2 in the face of l-buthionine (S,R)-sulfoximine -induced oxidative stress is independent of estrogen receptor-\u03b1, estrogen receptor-\u03b2 or G protein-coupled receptor 30 as shown by the inability of either ICI 182,780 or G15 to inhibit the E2-mediated protection. These cytoprotective effects appear to be dependent on antioxidant properties and the phenolic structure of estradiol as demonstrated by the observation that all phenolic compounds tested were protective, whereas all nonphenolic compounds were inactive, and the observation that the phenolic compounds reduced the levels of reactive oxygen species, whereas the nonphenolic compounds did not. These data show for the first time that phenolic E2-like compounds are potent protectors against oxidative stress-induced cell death in FRDA fibroblasts and are possible candidate drugs for the treatment and prevention of FRDA symptoms.<\/jats:p>","DOI":"10.1210\/en.2011-0184","type":"journal-article","created":{"date-parts":[[2011,5,4]],"date-time":"2011-05-04T00:35:27Z","timestamp":1304469327000},"page":"2742-2749","source":"Crossref","is-referenced-by-count":29,"title":["Estrogen Protection in Friedreich's Ataxia Skin Fibroblasts"],"prefix":"10.1210","volume":"152","author":[{"given":"Timothy E.","family":"Richardson","sequence":"first","affiliation":[{"name":"Institute for Aging and Alzheimer's Disease Research, Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, Texas 76107"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Hua","family":"Yang","sequence":"first","affiliation":[{"name":"Institute for Aging and Alzheimer's Disease Research, Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, Texas 76107"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wen","sequence":"first","affiliation":[{"name":"Institute for Aging and Alzheimer's Disease Research, Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, Texas 76107"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Simpkins","sequence":"first","affiliation":[{"name":"Institute for Aging and Alzheimer's Disease Research, Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, Texas 76107"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2011,5,3]]},"reference":[{"key":"2020071612462541100_B1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/hmg\/9.2.275","article-title":"Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia.","volume":"9","author":"Bradley","year":"2000","journal-title":"Hum Mol Genet"},{"key":"2020071612462541100_B2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1399-0004.1990.tb03566.x","article-title":"Friedreich's ataxia: a descriptive epidemiological study in an Italian population.","volume":"38","author":"Leone","year":"1990","journal-title":"Clin Genet"},{"key":"2020071612462541100_B3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0960-8966(98)00039-X","article-title":"Molecular genetics and pathogenesis of Friedreich ataxia.","volume":"8","author":"Pandolfo","year":"1998","journal-title":"Neuromuscul Disord"},{"key":"2020071612462541100_B4","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrneurol.2009.26","article-title":"Diagnosis and treatment of Friedreich ataxia: a European perspective.","volume":"5","author":"Schulz","year":"2009","journal-title":"Nat Rev Neurol"},{"key":"2020071612462541100_B5","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(83)92879-9","article-title":"Classification of the hereditary ataxias and paraplegias.","volume":"1","author":"Harding","year":"1983","journal-title":"Lancet"},{"key":"2020071612462541100_B6","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","article-title":"Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.","volume":"271","author":"Campuzano","year":"1996","journal-title":"Science"},{"key":"2020071612462541100_B7","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1161\/01.CIR.95.9.2247","article-title":"Correlation between left ventricular hypertrophy and GAA trinucleotide repeat length in Friedreich's ataxia.","volume":"95","author":"Isnard","year":"1997","journal-title":"Circulation"},{"key":"2020071612462541100_B8","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1089\/ars.2006.8.438","article-title":"Friedreich's ataxia: from disease mechanisms to therapeutic interventions.","volume":"8","author":"Lodi","year":"2006","journal-title":"Antioxid Redox Signal"},{"key":"2020071612462541100_B9","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/hmg\/6.8.1261","article-title":"The Friedreich ataxia GAA triplet repeat: permutation and normal alleles.","volume":"6","author":"Montermini","year":"1997","journal-title":"Hum Mol Genet"},{"key":"2020071612462541100_B10","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ygeno.2006.06.015","article-title":"GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology.","volume":"88","author":"Al-Mahdawi","year":"2006","journal-title":"Genomics"},{"key":"2020071612462541100_B11","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1126\/science.276.5319.1709","article-title":"Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin.","volume":"276","author":"Babcock","year":"1997","journal-title":"Science"},{"key":"2020071612462541100_B12","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1096\/fj.03-0240fje","article-title":"Mitochondria-targeted antioxidants protect Friedreich ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants.","volume":"17","author":"Jauslin","year":"2003","journal-title":"FASEB J"},{"key":"2020071612462541100_B13","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1093\/hmg\/11.24.3055","article-title":"A cellular model for Friedreich ataxia reveals small-molecule glutathione peroxidase mimetics as novel treatment strategy.","volume":"11","author":"Jauslin","year":"2002","journal-title":"Hum Mol Genet"},{"key":"2020071612462541100_B14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/ng1097-215","article-title":"Aconitase and mitochondrial iron-sulfur protein deficiency in Friedreich ataxia.","volume":"17","author":"R\u00f6tig","year":"1997","journal-title":"Nat Genet"},{"key":"2020071612462541100_B15","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s007020050099","article-title":"Abnormalities of mitochondrial enzymes in Alzheimer disease.","volume":"105","author":"Gibson","year":"1998","journal-title":"J Neural Transm"},{"key":"2020071612462541100_B16","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.bbabio.2010.01.025","article-title":"Mitochondrial respiratory chain super-complex I-III in physiology and pathology.","volume":"1797","author":"Lenaz","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"2020071612462541100_B17","first-page":"232","article-title":"Mitochondrial complex I: structure, function, and implications in neurodegeneration.","volume":"55","author":"Lenaz","year":"2006","journal-title":"Ital J Biochem"},{"key":"2020071612462541100_B18","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/0006-291X(89)91141-8","article-title":"Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease.","volume":"163","author":"Mizuno","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612462541100_B19","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ana.410260606","article-title":"Abnormalities of the electron transport chain in idiopathic Parkinson's disease.","volume":"26","author":"Parker","year":"1989","journal-title":"Ann Neurol"},{"key":"2020071612462541100_B20","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.brainresrev.2007.04.007","article-title":"Mitochondrial mechanisms of estrogen neuroprotection.","volume":"57","author":"Simpkins","year":"2008","journal-title":"Brain Res Rev"},{"key":"2020071612462541100_B21","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1056\/NEJM199610173351601","article-title":"Clinical and genetic abnormalities in patients with Friedreich's ataxia.","volume":"335","author":"D\u00fcrr","year":"1996","journal-title":"N Engl J Med"},{"key":"2020071612462541100_B22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1017\/S0317167100025464","article-title":"Clinical description and roentgenologic evaluation of patients with Friedreich's ataxia.","volume":"3","author":"Geoffroy","year":"1976","journal-title":"Can J Neurol Sci"},{"key":"2020071612462541100_B23","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1161\/01.CIR.102.11.1276","article-title":"Echocardiographic characterization of cardiomyopathy in Friedreich's ataxia with tissue Doppler echocardiographically derived myocardial velocity gradients.","volume":"102","author":"Dutka","year":"2000","journal-title":"Circulation"},{"key":"2020071612462541100_B24","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/brain\/104.3.589","article-title":"Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features.","volume":"104","author":"Harding","year":"1981","journal-title":"Brain"},{"key":"2020071612462541100_B25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/mcne.1994.1036","article-title":"Estradiol treatment increases viability of glioma and neuroblastoma cells in vitro.","volume":"5","author":"Bishop","year":"1994","journal-title":"Mol Cell Neurosci"},{"key":"2020071612462541100_B26","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1006\/bbrc.1995.2647","article-title":"17-\u03b2 estradiol protects neurons from oxidative stress induced cell death in vitro.","volume":"216","author":"Behl","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612462541100_B27","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1046\/j.1471-4159.1996.66051836.x","article-title":"Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury and amyloid \u03b2-peptide toxicity in hippocampal neurons.","volume":"66","author":"Goodman","year":"1996","journal-title":"J Neurochem"},{"key":"2020071612462541100_B28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0304-3940(96)12760-9","article-title":"Estrogen protects primary cortical neurons from glutamate toxicity.","volume":"212","author":"Singer","year":"1996","journal-title":"Neurosci Lett"},{"key":"2020071612462541100_B29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mce.2008.04.013","article-title":"Estrogen actions on mitochondria-physiological and pathological implications.","volume":"290","author":"Simpkins","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"2020071612462541100_B30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.yfrne.2009.04.013","article-title":"Role of protein phosphatases and mitochondria in the neuroprotective effects of estrogens.","volume":"30","author":"Simpkins","year":"2009","journal-title":"Front Neuroendocrinol"},{"key":"2020071612462541100_B31","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/ddr.20047","article-title":"Neuroprotective effects of estratriene analogs: structure-activity relationships and molecular optimization.","volume":"66","author":"Perez","year":"2006","journal-title":"Drug Dev Res"},{"key":"2020071612462541100_B32","doi-asserted-by":"crossref","first-page":"11741","DOI":"10.1073\/pnas.2032621100","article-title":"Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection.","volume":"100","author":"Prokai","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612462541100_B33","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.steroids.2007.10.011","article-title":"Mechanistic investigation on the antioxidant action of a neuroprotective estrogen derivative.","volume":"73","author":"Prokai-Tatrai","year":"2008","journal-title":"Steroids"},{"key":"2020071612462541100_B34","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1046\/j.1471-4159.2001.00271.x","article-title":"Estradiol protects against ATP depletion, mitochondrial membrane potential decline and the generation of reactive oxygen species induced by 3-nitroproprionic acid in SK-N-SH human neuroblastoma cells.","volume":"77","author":"Wang","year":"2001","journal-title":"J Neurochem"},{"key":"2020071612462541100_B35","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1167\/iovs.02-0841","article-title":"Oxidative damage to human lens epithelial cells in culture: estrogen protection of mitochondrial potential, ATP, and cell viability.","volume":"44","author":"Wang","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2020071612462541100_B36","doi-asserted-by":"crossref","first-page":"15148","DOI":"10.1073\/pnas.0802379105","article-title":"Estrogens directly potentiate neuronal L-type Ca2+ channels.","volume":"105","author":"Sarkar","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612462541100_B37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11357-009-9119-y","article-title":"Loss of estrogen receptor \u03b2 decreases mitochondrial energetic potential and increases thrombogenicity of platelets in aged female mice.","volume":"32","author":"Jayachandran","year":"2010","journal-title":"Age (Dordr)"},{"key":"2020071612462541100_B38","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1196\/annals.1347.008","article-title":"Development of 17\u03b1-estradiol as a neuroprotective therapeutic agent: rationale and results from a phase I clinical study.","volume":"1052","author":"Dykens","year":"2005","journal-title":"Ann NY Acad Sci"},{"key":"2020071612462541100_B39","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1124\/jpet.107.132308","article-title":"Estrogen receptor-independent neuroprotection via protein phosphatase preservation and attenuation of persistent extracellular signal-regulated kinase 1\/2 activation.","volume":"324","author":"Yi","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"2020071612462541100_B40","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1111\/j.1476-5381.1995.tb15085.x","article-title":"Comparison between novel steroid-like and conventional nonsteroidal antioestrogens in inhibiting oestradiol- and IGF-I-induced proliferation of human breast cancer-derived cells.","volume":"116","author":"de Cupis","year":"1995","journal-title":"Br J Pharmacol"},{"key":"2020071612462541100_B41","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3171\/jns.1997.87.5.0724","article-title":"Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat.","volume":"87","author":"Simpkins","year":"1997","journal-title":"J Neurosurg"},{"key":"2020071612462541100_B42","first-page":"149","article-title":"Human cultured skin fibroblasts express estrogen receptor \u03b1 and \u03b2.","volume":"10","author":"Haczynski","year":"2002","journal-title":"Int J Mol Med"},{"key":"2020071612462541100_B43","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.1158\/0008-5472.CAN-10-0408","article-title":"Nuclear alternate estrogen receptor GPR30 mediates 17\u03b2-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts.","volume":"70","author":"Madeo","year":"2010","journal-title":"Cancer Res"},{"key":"2020071612462541100_B44","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11010-007-9429-2","article-title":"Protective effects of Fe-Aox29, a novel antioxidant derived from a molecular combination of Idebenone and vitamin E, in immortalized fibroblasts and fibroblasts from patients with Friedreich ataxia.","volume":"302","author":"Jauslin","year":"2007","journal-title":"Mol Cell Biochem"},{"key":"2020071612462541100_B45","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1093\/hmg\/ddn127","article-title":"Iron-dependent regulation of frataxin expression: implications for treatment of Friedreich ataxia.","volume":"17","author":"Li","year":"2008","journal-title":"Hum Mol Genet"},{"key":"2020071612462541100_B46","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.stem.2010.09.014","article-title":"Friedreich's ataxia induced pluripotent stem cells model intergenerational GAA-TTC triplet repeat instability.","volume":"7","author":"Ku","year":"2010","journal-title":"Cell Stem Cell"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/152\/7\/2742\/9039017\/endo2742.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/152\/7\/2742\/9039017\/endo2742.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T21:50:51Z","timestamp":1594936251000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/152\/7\/2742\/2457192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,3]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2011-0184","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,3]]}}}